Medium- to long-term product and menu development by the Future Creation Office
First written in FY2018. 6 of 10 entries say "Restated". Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The segment's research and development activities during the fiscal year under review were as follows. R&D expenses are included in selling, general and administrative expenses, and totaled ¥77 million.」
The company recognized ¥77 million in R&D expenses and developed new products and menu items in the dressing, pasta, frozen food, soup and restaurant businesses. - FY2026-H1RestatedAnnual report
「Group-wide research and development expenses for the interim consolidated period are included in selling, general and administrative expenses and totaled ¥39 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated period.」
Although it stated that there had been no material changes in research and development activities, it disclosed total R&D expenses of ¥39 million for the interim consolidated accounting period. - FY2024AdvancedAnnual report
「The segment research and development activities for the consolidated fiscal year were as follows. Research and development expenses are included in selling, general and administrative expenses. The total of ¥95 million represents company-wide research expenses that cannot be allocated to individual segments.」
The company recorded ¥95 million in research and development expenses and pursued the development of new products and menus in the dressing, pasta, frozen food, soup and restaurant categories. - FY2024-Q3RestatedAnnual report
「Group-wide research and development expenses for the cumulative nine-month consolidated period are included in selling, general and administrative expenses and totaled ¥73 million. There were no material changes in the status of the Group's research and development activities during the cumulative nine-month consolidated period.」
The company disclosed total research and development expenses of ¥73 million for the cumulative nine-month period, while stating that there were no material changes in its research and development activities. - FY2024-Q2RestatedAnnual report
「Group-wide research and development expenses for the cumulative six-month consolidated period are included in selling, general and administrative expenses and totaled ¥48 million. There were no material changes in the status of the Group's research and development activities during the cumulative six-month consolidated period.」
The company disclosed total research and development expenses of ¥48 million for the cumulative six-month period, while stating that there were no material changes in its research and development activities. - FY2024-Q1RestatedAnnual report
「Group-wide research and development expenses for the cumulative three-month consolidated period are included in selling, general and administrative expenses and totaled ¥24 million. There were no material changes in the status of the Group's research and development activities during the cumulative three-month consolidated period.」
The company disclosed total research and development expenses of ¥24 million for the cumulative three-month period, while stating that there were no material changes in its research and development activities. - FY2023-Q3RestatedAnnual report
「Group-wide research and development expenses for the cumulative nine-month consolidated period are included in selling, general and administrative expenses and totaled ¥77 million. There were no material changes in the status of the Group's research and development activities during the cumulative nine-month consolidated period.」
The company disclosed total research and development expenses of ¥77 million for the cumulative nine-month period, while stating that there were no material changes in its research and development activities. - FY2023-Q2RestatedAnnual report
「Group-wide research and development expenses for the cumulative six-month consolidated period are included in selling, general and administrative expenses and totaled ¥52 million. There were no material changes in the status of the Group's research and development activities during the cumulative six-month consolidated period.」
The company disclosed total research and development expenses of ¥52 million for the cumulative six-month period, while stating that there were no material changes in its research and development activities. - FY2022AdvancedAnnual report
「The segment research and development activities for the consolidated fiscal year were as follows. Research and development expenses are included in selling, general and administrative expenses. The total of ¥90 million represents company-wide research expenses that cannot be allocated to individual segments.」
With the development of new products and menus as a medium- to long-term priority, the company recorded ¥90 million in research and development expenses and pursued development in the food, frozen food, soup and restaurant fields. - FY2018First statedAnnual report
「To make the development of new products and menus a key priority in its growth strategy, the company established the Future Creation Office as a new organization within the Branding Division and will conduct product development from a medium- to long-term perspective.」
The company positioned the development of new products and menus as a key growth strategy priority and established a new organization.